Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Science 37 Holdings, Inc. - Common Stock (NQ:SNCE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Science 37 Holdings, Inc. - Common Stock

< Previous 1 2 Next >
Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
Science 37’s Virtual Site Model for Clinical Research Impresses in First-of-its-Kind FDA Inspection 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”
From Science 37, Inc.
Via GlobeNewswire
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x Greater Enrollment Velocity Compared to Traditional Brick-and-Mortar Clinical Trial Sites 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment
New patent-protected, central recruitment leverages the Science 37 Metasite™ to accelerate enrollment and dramatically reduce site burden 
From Science 37, Inc.
Via GlobeNewswire
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE
From Kahn Swick & Foti, LLC
Via Business Wire
SCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCE
From Kahn Swick & Foti, LLC
Via Business Wire
SNCE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Science 37 Holdings, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath RentCorp (Nasdaq – MGRC), Science 37 Holdings, Inc. (Nasdaq – SNCE), Eagle Bulk Shipping Inc. (NYSE - EGLE), Cerevel Therapeutics Holdings, Inc. (Nasdaq –
From Brodsky & Smith LLC
Via GlobeNewswire
Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
Science 37 stockholders to receive $5.75 per share in cash 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Receives Top Honors in Everest PEAK Matrix®
Science 37 emerges as the only clinical trial site to be recognized as a Leader in Decentralized Clinical Trials 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Third Quarter 2023 Financial Results
From Science 37, Inc.
Via GlobeNewswire
Science 37 to Report Third Quarter 2023 Financial Results on November 7, 2023
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List
From Science 37, Inc.
Via GlobeNewswire
Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023
From Science 37, Inc.
Via GlobeNewswire
Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan
From Science 37, Inc.
Via GlobeNewswire
Science 37 to Participate in H.C. Wainwright 25th Annual Global Investment Conference
From Science 37, Inc.
Via GlobeNewswire
Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Second Quarter 2023 Financial Results
From Science 37, Inc.
Via GlobeNewswire
Science 37 to Report Second Quarter 2023 Financial Results on August 8, 2023
From Science 37, Inc.
Via GlobeNewswire
Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)
Science 37's Metasite to Facilitate Phase 3 Study Enrollment by Expanding Access and Maximizing Convenience for Patients 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"
Science 37's unified platform that powers the Metasite receives award for outstanding digital health and technology innovation 
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports First Quarter 2023 Financial Results
From Science 37, Inc.
Via GlobeNewswire
Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Science 37, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.